The purpose of the high risk colon cancer clinic core is to provide the mechanism and facility for investigation and clinical care of individuals and families with inherited risk of colon cancer. The core will serve the clinical and basic projects of this application. The University of Utah Health Science Center is currently expanding its general clinical research center with NIH funding to facilitate the high risk colon cancer clinic and other cancer studies. Activities of this core will include: mail and telephone subject contact, demographic and epidemiological data gathering, study registration, administration of informed consent, blood and tissue sampling, endoscopic examination and clinical care. Clinical care extends to genetic counseling, patient education, cancer screening, and cancer diagnosis and follow-up through colonoscopy, upper GI endoscopy and appropriate patient referral. Computerized data management activities administered as part of the clinic include a high risk colon cancer registry, data management of clinical and medical information, patient tracking, and blood and tissue sampling which involves acquisition, processing, storage, tracking and distribution. The clinic will be staffed by investigator physicians, nurses, coordinators, and genetic counselors. In view of both the clinical and basic aspects of this application, the high risk clinic will serve as a pivotal point of interaction between subjects, clinical investigators, basic scientists and information managers. It will also allow research to be translation, in that genetic and laboratory findings will be appropriately applied to disease prevention in kindreds under study.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA073992-03
Application #
6344754
Study Section
Project Start
2000-08-16
Project End
2001-05-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$100,568
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Fuller, Andrew K; Bice, Benjamin D; Venancio, Ashlee R et al. (2018) A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model. J Vis Exp :
Bice, Benjamin D; Stephens, Megan R; Georges, Stephanie J et al. (2017) Environmental Enrichment Induces Pericyte and IgA-Dependent Wound Repair and Lifespan Extension in a Colon Tumor Model. Cell Rep 19:760-773
Jewel Samadder, N; Valentine, John F; Guthery, Stephen et al. (2017) Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Dig Dis Sci 62:2126-2132
Gan, Meng; Boothe, Dustin; Neklason, Deborah W et al. (2017) Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis. J Gastrointest Oncol 8:643-649
Samadder, N Jewel; Neklason, Deborah W; Boucher, Kenneth M et al. (2016) Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA 315:1266-75
Li, Jun; Woods, Susan L; Healey, Sue et al. (2016) Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. Am J Hum Genet 98:830-842
Kanth, Priyanka; Bronner, Mary P; Boucher, Kenneth M et al. (2016) Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer Prev Res (Phila) 9:456-65
Samadder, N Jewel; Smith, Ken Robert; Hanson, Heidi et al. (2016) Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol 2:340-6

Showing the most recent 10 out of 108 publications